Last reviewed · How we verify
NCT03414580
Analysis of Volatile Organic Compounds in the Exhaled Air in Inflammatory Bowel Disease
trial testing Breath sampling for volatile organic compounds in Volatile Organic Compounds in 90 participants. Status unknown.
1 June 2021
Quick facts
| Lead sponsor | Keimyung University Dongsan Medical Center |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 20 February 2018 |
| Primary completion | 1 June 2021 |
| Estimated completion | 1 June 2021 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Breath sampling for volatile organic compounds
Conditions studied
- Volatile Organic Compounds — all drugs for Volatile Organic Compounds →
- Inflammatory Bowel Disease — all drugs for Inflammatory Bowel Disease →
Sponsor
Keimyung University Dongsan Medical Center
Who can join
Adults 18 to 80, any sex, with Volatile Organic Compounds or Inflammatory Bowel Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The availability of noninvasive biomarkers for diagnosis and stratification of inflammatory bowel disease (IBD) courses is lacking. Thus, the aim of this study is to evaluated the accuracy of exhaled breath volatile metabolite analysis on diagnosis and stratification of patients with inflammatory bowel disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03414580
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Volatile Organic Compounds
Currently open trials in the same condition.
- NCT06767488 — Breathomics in the Diagnosis and Prediction of Radiotherapy-Induced Oropharyngeal Mucositis in Head and Neck Tumors · recruiting
- NCT05819996 — Addressing Tetrachloroethylene Exposure in an Impacted Community · NA · recruiting
- NCT04081428 — Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT · active not recruiting
Other Keimyung University Dongsan Medical Center trials
Trials by the same sponsor.
- NCT06963424 — Pain Relief and and Peripheral Perfusion Index During Erector Spinae Block · NA · completed
- NCT06471907 — Comparison of Pain Relief and Peripheral Perfusion Index · NA · recruiting
- NCT07210073 — Video Education to Improve Blood Pressure Control in Patients With Ischemic Heart Disease and Hypertension (V-EDUCATE) · NA · completed
- NCT06149299 — Great Occipital Nerve Block Using Different Approach · NA · unknown
- NCT05705362 — Simple Crossover Versus Side Branch Opening in Patients With Non-Left Main Bifurcation Lesion · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03414580 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Keimyung University Dongsan Medical Center
- Last refreshed: 3 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03414580.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing